A detailed history of Pro Share Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 3,298 shares of MDGL stock, worth $715,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,298
Previous 4,054 18.65%
Holding current value
$715,666
Previous $1.08 Million 14.7%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$193.33 - $291.99 $146,157 - $220,744
-756 Reduced 18.65%
3,298 $923,000
Q1 2024

May 08, 2024

BUY
$171.37 - $283.23 $58,779 - $97,147
343 Added 9.24%
4,054 $1.08 Million
Q4 2023

Feb 14, 2024

BUY
$120.4 - $237.13 $88,373 - $174,053
734 Added 24.66%
3,711 $858,000
Q3 2023

Nov 13, 2023

BUY
$146.04 - $225.78 $3,212 - $4,967
22 Added 0.74%
2,977 $434,000
Q2 2023

Aug 10, 2023

BUY
$203.88 - $312.0 $40,572 - $62,088
199 Added 7.22%
2,955 $682,000
Q1 2023

May 11, 2023

SELL
$231.06 - $307.08 $68,624 - $91,202
-297 Reduced 9.73%
2,756 $667,000
Q4 2022

Feb 02, 2023

BUY
$58.39 - $296.54 $178,264 - $905,336
3,053 New
3,053 $886,000
Q2 2022

Aug 01, 2022

SELL
$58.04 - $100.2 $230,767 - $398,395
-3,976 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$55.89 - $101.89 $56,057 - $102,195
-1,003 Reduced 20.14%
3,976 $391,000
Q4 2021

Feb 08, 2022

SELL
$72.34 - $95.09 $1,446 - $1,901
-20 Reduced 0.4%
4,979 $422,000
Q3 2021

Nov 12, 2021

SELL
$78.35 - $105.02 $72,630 - $97,353
-927 Reduced 15.64%
4,999 $399,000
Q2 2021

Aug 13, 2021

BUY
$97.2 - $137.59 $133,552 - $189,048
1,374 Added 30.18%
5,926 $577,000
Q1 2021

May 14, 2021

BUY
$108.54 - $125.2 $24,530 - $28,295
226 Added 5.22%
4,552 $532,000
Q4 2020

Feb 09, 2021

BUY
$110.06 - $133.7 $476,119 - $578,386
4,326 New
4,326 $481,000
Q4 2018

Feb 14, 2019

SELL
$94.77 - $215.54 $108,227 - $246,146
-1,142 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$207.3 - $300.31 $77,944 - $112,916
376 Added 49.09%
1,142 $245,000
Q2 2018

Aug 13, 2018

BUY
$101.55 - $313.9 $77,787 - $240,447
766 New
766 $214,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.71B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.